IGF2BP3 and urinary bladder cancer: Additionally, immunohistochemical analysis indicated a correlation between increased IGF2BP3 expression and chemotherapy drug resistance in bladder cancer patients, suggesting its potential involvement in mediating resistance to chemotherapy.